Trials / Completed
CompletedNCT07272408
Remote Ischemic Conditioning in Patients Undergoing Primary Percutaneous Coronary Intervention
Impact of Remote Ischemic Conditioning in Patients Undergoing Primary Percutaneous Coronary Intervention
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Helwan University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to detect the effects of remote ischemic conditioning on infarct size, global contractility, morbidity, mortality, and renal function in patients undergoing primary percutaneous coronary intervention.
Detailed description
Myocardial infarction (MI) generally refers to segmental (regional) myocardial necrosis, typically endocardial in location, secondary to occlusion of an epicardial artery. Primary percutaneous coronary intervention (PPCI) is a reperfusion therapy that is carried out in patients who usually have ST-segment elevation MI (STEMI) within a specific time window. During ischemia, metabolic acidosis occurs due to anaerobic metabolism, and ischemic injury ensues. After restoration of blood supply, reactive oxygen species (ROS) production and local inflammation increase secondary injury.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Remote ischemic conditioning | Remote ischemic conditioning (RIC) was applied to those patients. |
| PROCEDURE | Normal primary percutaneous coronary intervention | Patients followed the standard primary percutaneous coronary intervention pathway. |
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2023-12-30
- Completion
- 2023-12-30
- First posted
- 2025-12-09
- Last updated
- 2025-12-09
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07272408. Inclusion in this directory is not an endorsement.